在阿尔茨海默病模型中,髓功能障碍驱动了粉样β沉积
Constanze Depp1, Ting Sun2, Andrew Octavian Sasmita2
1Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany. depp@mpinat.mpg.de.
Nature
|May 31, 2023
概括
与年龄相关的髓损伤, 不仅仅是粉样质斑块, 驱动阿尔茨海默病 (AD) 的发展. 保护寡细胞和髓完整性可能为阿尔茨海默病提供新的治疗策略.
科学领域:
- 神经科学
- 老龄化研究
- 神经退行性疾病
背景情况:
- 阿尔茨海默病的发病率随着年龄的增长而上升,
- 大脑衰老会影响寡细胞和髓的完整性,可能导致神经炎症.
- 骨干细胞对轴突能量代谢和神经元健康至关重要.
研究的目的:
- 调查骨髓质完整性损失是否是AD中粉样β (Aβ) 沉积的上游风险因素.
- 确定将髓功能障碍与粉样沉积联系起来的遗传途径.
- 了解微质在AD与髓质缺陷中的作用.
主要方法:
- 使用AD的小鼠模型与髓功能障碍的遗传途径.
- 在AD小鼠模型中进行批量和单细胞转录组.
- 分析了Aβ沉积,轴突完整性和微质反应.
主要成果:
- 在AD小鼠模型中,髓功能障碍和脱髓化损伤被确定为amyloid沉积的驱动因素.
- 骨髓蛋白缺陷导致了轴突胀中的Aβ产生机制积累,并增加了粉样蛋白前体的裂变.
- 虽然小质细胞的数量增加了,但它们无法清除斑块,并因髓质细胞损伤而分心,显示出与疾病相关的显著小质细胞特征.
结论:
- 年龄相关的髓结构缺陷促进了Aβ斑块的形成,作为一种上游AD风险因素.
- 骨髓质细胞健康和髓质完整性是延缓AD发病和进展的潜在治疗点.
- 观察到明显的微质对髓质损伤和粉样质斑块的反应,影响斑块清除.
相关概念视频
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Alzheimer's Disease: Overview
539
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
539


